New vaccine combats gastroenteritis

GlaxoSmithKline has launched Rotarix, a live attenuated rotavirus vaccine, for the prevention of gastroenteritis due to rotavirus infection.

Rotarix is an oral vaccine indicated for infants from the age of six weeks. The vaccination course consists of two oral doses. The first dose is administered to infants from the age of six weeks, with the second dose being given after an interval of at least four weeks.

The vaccination course should preferably be given before 16 weeks of age, but must be completed by the age of 24 weeks.

Rotarix is presented as a powder and solvent for oral suspension. The cost of a single dose is £41.38.

Further information: GlaxoSmithKline, Stockley Park West, Uxbridge, Middlesex UB11 1BT. Tel: (0800) 221441.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Asthma drug hailed as first non-hospital treatment for COVID-19

Asthma drug hailed as first non-hospital treatment for COVID-19

Inhaled budesonide is the first widely available, inexpensive...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Under-30s to be offered alternative to AstraZeneca COVID-19 vaccine after reports of rare blood clots